- Thomson Medical Group (SGX:A50)’s 2H24 headline PATMI of S$13.4m (-2.5% y-o-y) came in below our projection, mainly due to higher-than-expected opex and finance costs following the completion of acquisition of FV Hospital in Vietnam. This was partly offset by reversal of impairment losses on investment property & development property recognised previously.
Vietnam hospital provides strong addition
- - Read this at SGinvestors.io -
- However, the increase was partially offset by the cessation of project-related services, such as managing the vaccination centres and the Transitional Care Facilities (TCF) in Singapore in Dec 2023, as well as lower patient loads and case intensity, termination of certain customer contracts and discounts given to customers in Malaysia.
Broadening its reach to be a regional player
- - Read this at SGinvestors.io -
- To drive synergies across its Southeast Asia footprint, Thomson Medical is also expanding its doctor network, enhancing digital patient engagement and sharing clinical expertise across its key markets.
More government support for new parents
- Read more at SGinvestors.io.
Above is the excerpt from report by Maybank Research.
Clients of Maybank Securities may be the first to access the full report in PDF @ https://www.maybanktrade.com.sg/.
Eric Ong Maybank Research | https://www.maybank-ke.com.sg/ 2024-08-27
Previous report by Maybank:
2024-02-27 Thomson Medical Group - Growing ASEAN Footprint; The Next Healthcare Giant.
Price targets by other brokers at Thomson Medical Target Prices.
Listing of research reports at Thomson Medical Analyst Reports.
Relevant links:
Thomson Medical Share Price History,
Thomson Medical Announcements,
Thomson Medical Dividends & Corporate Actions,
Thomson Medical News Articles
